Literature DB >> 19131643

The pro-fibrotic factor IGFBP-5 induces lung fibroblast and mononuclear cell migration.

Hidekata Yasuoka1, Yukie Yamaguchi, Carol A Feghali-Bostwick.   

Abstract

We have previously shown that insulin-like growth factor-binding protein-5 (IGFBP-5) is overexpressed in fibrotic lung tissues and that it induces production of extracellular matrix components such as collagen and fibronectin both in vitro and in vivo. We recently observed mononuclear cell infiltration in lung tissues of mice expressing IGFBP-5. We therefore examined the role of IGFBP-5 on the migration of immune cells. Migration assays demonstrated that IGFBP-5 induced migration of peripheral blood mononuclear cells (PBMCs) in a dose-dependent manner. Preferential migration of monocytes/macrophages, natural killer cells, and T cells was observed. Moreover, the CD4/CD8 ratio of migrating cells was significantly higher in vitro and in vivo in response to IGFBP-5. IGFBP-5 resulted in preferential migration of activated CD4(+) T cells and monocytes. Interestingly, IGFBP-5 also induced migration of primary human lung fibroblasts. Exogenous administration of IGFBP-5 induced activation of mitogen-activated protein kinase (MAPK) signaling cascade but not PI3K in PBMCs. IGFBP-5-induced migration was blocked by the MEK1/2 inhibitor U0126, suggesting that IGFBP-5-induced migration occurs via MAPK activation. Furthermore, monocytes treated with recombinant IGFBP-5 expressed the mesenchymal markers alpha-smooth muscle actin and fibronectin in vitro and in vivo, suggesting that IGFBP-5 can induce the transformation of monocytes into mesenchymal cells. Collectively, our results suggest that IGFBP-5 induces cell migration via MAPK-dependent and IGF-I-independent mechanisms.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19131643      PMCID: PMC2715907          DOI: 10.1165/rcmb.2008-0211OC

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  50 in total

Review 1.  Fibrotic disease and the T(H)1/T(H)2 paradigm.

Authors:  Thomas A Wynn
Journal:  Nat Rev Immunol       Date:  2004-08       Impact factor: 53.106

Review 2.  Alveolitis: the key to the interstitial lung disorders.

Authors:  B A Keogh; R G Crystal
Journal:  Thorax       Date:  1982-01       Impact factor: 9.139

3.  Insulin-like growth factor-binding protein-5 (IGFBP-5) stimulates growth and IGF-I secretion in human intestinal smooth muscle by Ras-dependent activation of p38 MAP kinase and Erk1/2 pathways.

Authors:  John F Kuemmerle; Huiping Zhou
Journal:  J Biol Chem       Date:  2002-03-28       Impact factor: 5.157

Review 4.  IGF-binding protein-5: flexible player in the IGF system and effector on its own.

Authors:  M R Schneider; E Wolf; A Hoeflich; H Lahm
Journal:  J Endocrinol       Date:  2002-03       Impact factor: 4.286

5.  Regulation of vascular smooth muscle cell responses to insulin-like growth factor (IGF)-I by local IGF-binding proteins.

Authors:  Tzefu Hsieh; Rebecca E Gordon; David R Clemmons; Walker H Busby; Cunming Duan
Journal:  J Biol Chem       Date:  2003-08-12       Impact factor: 5.157

6.  Human circulating CD14+ monocytes as a source of progenitors that exhibit mesenchymal cell differentiation.

Authors:  Masataka Kuwana; Yuka Okazaki; Hiroaki Kodama; Keisuke Izumi; Hidekata Yasuoka; Yoko Ogawa; Yutaka Kawakami; Yasuo Ikeda
Journal:  J Leukoc Biol       Date:  2003-07-22       Impact factor: 4.962

Review 7.  MAP kinases and cell migration.

Authors:  Cai Huang; Ken Jacobson; Michael D Schaller
Journal:  J Cell Sci       Date:  2004-09-15       Impact factor: 5.285

8.  Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis.

Authors:  Roderick J Phillips; Marie D Burdick; Kurt Hong; Marin A Lutz; Lynne A Murray; Ying Ying Xue; John A Belperio; Michael P Keane; Robert M Strieter
Journal:  J Clin Invest       Date:  2004-08       Impact factor: 14.808

Review 9.  Circulating fibrocytes: collagen-secreting cells of the peripheral blood.

Authors:  Timothy E Quan; Shawn Cowper; Sou-Pan Wu; Linda K Bockenstedt; Richard Bucala
Journal:  Int J Biochem Cell Biol       Date:  2004-04       Impact factor: 5.085

10.  Fibronectin binds insulin-like growth factor-binding protein 5 and abolishes Its ligand-dependent action on cell migration.

Authors:  Qijin Xu; Ben Yan; Shenghua Li; Cunming Duan
Journal:  J Biol Chem       Date:  2003-11-24       Impact factor: 5.157

View more
  23 in total

1.  Defining the disulfide bonds of insulin-like growth factor-binding protein-5 by tandem mass spectrometry with electron transfer dissociation and collision-induced dissociation.

Authors:  Mahta Nili; Aditi Mukherjee; Ujwal Shinde; Larry David; Peter Rotwein
Journal:  J Biol Chem       Date:  2011-11-22       Impact factor: 5.157

2.  CCN1: a novel inflammation-regulated biphasic immune cell migration modulator.

Authors:  Madlen Löbel; Sandra Bauer; Christian Meisel; Andreas Eisenreich; Robert Kudernatsch; Juliane Tank; Ursula Rauch; Uwe Kühl; Heinz-Peter Schultheiss; Hans-Dieter Volk; Wolfgang Poller; Carmen Scheibenbogen
Journal:  Cell Mol Life Sci       Date:  2012-04-20       Impact factor: 9.261

3.  Association between a functional polymorphism (-1195T>C) in the IGFBP5 promoter and head and neck cancer risk.

Authors:  Jiangong Niu; Yu-Jing Huang; Sheng Wei; Zhensheng Liu; Li-E Wang; Shine Chang; Robert M Chamberlain; Adel K El-Naggar; Erich M Sturgis; Qingyi Wei
Journal:  Head Neck       Date:  2010-10-14       Impact factor: 3.147

4.  Decreased caveolin-1 levels contribute to fibrosis and deposition of extracellular IGFBP-5.

Authors:  Yukie Yamaguchi; Hidekata Yasuoka; Donna B Stolz; Carol A Feghali-Bostwick
Journal:  J Cell Mol Med       Date:  2011-04       Impact factor: 5.310

Review 5.  Host responses in tissue repair and fibrosis.

Authors:  Jeremy S Duffield; Mark Lupher; Victor J Thannickal; Thomas A Wynn
Journal:  Annu Rev Pathol       Date:  2012-10-22       Impact factor: 23.472

6.  The fibrotic phenotype induced by IGFBP-5 is regulated by MAPK activation and egr-1-dependent and -independent mechanisms.

Authors:  Hidekata Yasuoka; Eileen Hsu; Ximena D Ruiz; Richard A Steinman; Augustine M K Choi; Carol A Feghali-Bostwick
Journal:  Am J Pathol       Date:  2009-07-23       Impact factor: 4.307

Review 7.  An ocular view of the IGF-IGFBP system.

Authors:  Dung V Nguyen; Sergio Li Calzi; Lynn C Shaw; Jennifer L Kielczewski; Hannah E Korah; Maria B Grant
Journal:  Growth Horm IGF Res       Date:  2013-04-08       Impact factor: 2.372

8.  Oral Epithelial Cells Distinguish between Candida Species with High or Low Pathogenic Potential through MicroRNA Regulation.

Authors:  Renáta Tóth; Attila Gácser; Márton Horváth; Gábor Nagy; Nóra Zsindely; László Bodai; Péter Horváth; Csaba Vágvölgyi; Joshua D Nosanchuk
Journal:  mSystems       Date:  2021-05-11       Impact factor: 6.496

Review 9.  Functional roles and clinical values of insulin-like growth factor-binding protein-5 in different types of cancers.

Authors:  Gökçe Güllü; Sevgi Karabulut; Mustafa Akkiprik
Journal:  Chin J Cancer       Date:  2012-02-07

10.  Insulin-like growth factor binding proteins-3 and -5: central mediators of fibrosis and promising new therapeutic targets.

Authors:  Kristen L Veraldi; Carol A Feghali-Bostwick
Journal:  Open Rheumatol J       Date:  2012-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.